GlassScriptPhysician profile
Deborah C Sherman
NPI 1104810449
$1,226.37
in general payments reported to CMS, 2019-2025
17 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $288 · 2021: $185 · 2022: $61.72 · 2023: $313 · 2024: $66.09 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $386.74 | 2019-2021 | |
| Hologic Sales and Service, LLC | $129.62 | 2019-2024 | Aptima |
| Boston Scientific Corporation | $106.56 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $106.39 | 2023 | Exparel |
| Merz North America, INC. | $106.33 | 2025 | |
| Ethicon US, LLC | $73.28 | 2023 | Enseal |
| Avion Pharmaceuticals | $57.88 | 2019-2023 | Balcoltra |
| Bayer Healthcare Pharmaceuticals INC. | $56.28 | 2022-2023 | |
| Abbvie INC. | $41.14 | 2019-2023 | Lo Loestrin Fe |
| Evofem Biosciences, INC. | $35.13 | 2023 | Phexxi |
| Vertical Pharmaceuticals, LLC | $25.14 | 2019 | |
| Lupin INC. | $19.18 | 2019 | |
| Organon LLC | $18.11 | 2022 | |
| Biogen, INC. | $18.06 | 2024 | Zurzuvae |
| Daiichi Sankyo INC. | $16.80 | 2023 | Injectafer |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.16 | 2024 | Sonicision |
| Shield Therapeutics INC | $14.57 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.